Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | The role of transplantation in MDS

Ryotaro Nakamura • 28 Sep 2022
SOHO 2022
Myelodysplastic Syndromes

In this video, Ryotaro Nakamura, MD, City of Hope, Duarte, CA, comments on the importance of allogeneic stem cell transplantation (alloSCT) in patients with myelodysplastic syndromes (MDS). This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Ryotaro Nakamura

1:44
Exciting advancements in the MDS space
Ryotaro Nakamura • 28 Sep 2022
2:35
Methods of optimizing transplantation in MDS
Ryotaro Nakamura • 28 Sep 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:19
Key clinical trials in MDS taking place in the US
Guillermo Garcia-Manero • 9 Apr 2024
1:34
Sequencing of agents in LR-MDS
Guillermo Garcia-Manero • 9 Apr 2024
1:21
HMAs for MDS- a party of one
Guillermo Garcia-Manero • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals